CM
OLMA icon

Caption Management’s Olema Pharmaceuticals OLMA Stock Holding History

Caption Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
+76,000
New +$1.69M 0.01% 988

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Caption Management's OLMA Position: Q1 2026 in Review

Caption Management opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 35,000 shares worth $522K. The stake represents ﹤0.01% of the portfolio and ranks #1199 among its holdings. This is a return to the name: Caption Management previously reported a position in OLMA as recently as Q4 2024.

Caption Management first reported a position in OLMA in Q4 2023 and has held it in 4 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Caption Management held 35,000 shares of Olema Pharmaceuticals worth $522K as of Q1 2026.
  • Olema Pharmaceuticals was a new Caption Management position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1199 holding.
  • Caption Management first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.